ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPcYuanyuan Cheng(Fudan University), Feng Tang(Shandong University of Technology)Cancer Cell InternationalJanuary 7, 202110.1186/s12935-020-01727-5Cited by 48SaveCiteExport RISWatch citationsRelated PapersMethionine intervention induces PD-L1 expression to enhance the immune checkpoint therapy response in MTAP-deleted osteosarcoma|Cell Reports Medicine|2025|20Additional file 1 of An initial study on the predictive value using multiple MRI characteristics for Ki-67 labeling index in glioma|Figshare|2023|0